|
|
@@ -0,0 +1,1104 @@
|
|
|
+<!DOCTYPE html>
|
|
|
+<html lang="zh-CN">
|
|
|
+<head>
|
|
|
+<meta charset="UTF-8">
|
|
|
+<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
|
|
+<meta name="description" content="老年痴呆 - 神经炎症、肠脑轴与主动健康：Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。">
|
|
|
+<meta name="keywords" content="阿尔茨海默病,神经炎症,肠脑轴,小胶质细胞,Aβ淀粉样斑块,tau蛋白缠结,神经退行性疾病,主动健康,预防医学">
|
|
|
+<meta property="og:title" content="老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福">
|
|
|
+<meta property="og:description" content="Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。">
|
|
|
+<meta property="og:type" content="article">
|
|
|
+<title>老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福</title>
|
|
|
+<style>
|
|
|
+ :root {
|
|
|
+ --bg-dark: #1a1a3a;
|
|
|
+ --bg-card: #FFFFFF;
|
|
|
+ --bg-alt: #f0f7f0;
|
|
|
+ --text-primary: #1a1a3a;
|
|
|
+ --text-secondary: #4a5568;
|
|
|
+ --text-muted: #718096;
|
|
|
+ --accent: #27ae60;
|
|
|
+ --accent-light: #eafaf1;
|
|
|
+ --blue: #2d7d9a;
|
|
|
+ --blue-light: #e8f4f8;
|
|
|
+ --green: #38a169;
|
|
|
+ --green-light: #f0fff4;
|
|
|
+ --orange: #dd6b20;
|
|
|
+ --orange-light: #fffaf0;
|
|
|
+ --purple: #805ad5;
|
|
|
+ --purple-light: #faf5ff;
|
|
|
+ --teal: #319795;
|
|
|
+ --teal-light: #e6fffa;
|
|
|
+ --font: system-ui, -apple-system, "PingFang SC", "Microsoft YaHei", "Noto Sans SC", sans-serif;
|
|
|
+ --max-width: 1080px;
|
|
|
+ --shadow-card: 0 4px 24px rgba(0,0,0,0.08);
|
|
|
+ --shadow-hover: 0 8px 40px rgba(0,0,0,0.12);
|
|
|
+ --radius: 16px;
|
|
|
+ }
|
|
|
+ * { margin: 0; padding: 0; box-sizing: border-box; }
|
|
|
+ html { scroll-behavior: smooth; }
|
|
|
+ body {
|
|
|
+ font-family: var(--font);
|
|
|
+ font-size: 1rem;
|
|
|
+ line-height: 1.8;
|
|
|
+ color: var(--text-primary);
|
|
|
+ background: #fff;
|
|
|
+ -webkit-font-smoothing: antialiased;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* HERO */
|
|
|
+ .hero {
|
|
|
+ position: relative;
|
|
|
+ background: linear-gradient(135deg, #1a1a3a 0%, #2d2d6b 40%, #3a3a8c 100%);
|
|
|
+ color: white;
|
|
|
+ padding: 6rem 1.5rem 4rem;
|
|
|
+ overflow: hidden;
|
|
|
+ min-height: 60vh;
|
|
|
+ display: flex;
|
|
|
+ align-items: center;
|
|
|
+ }
|
|
|
+ .hero::before {
|
|
|
+ content: '';
|
|
|
+ position: absolute;
|
|
|
+ inset: 0;
|
|
|
+ background:
|
|
|
+ radial-gradient(circle at 20% 30%, rgba(139,92,246,0.15) 0%, transparent 50%),
|
|
|
+ radial-gradient(circle at 80% 70%, rgba(99,102,241,0.1) 0%, transparent 50%);
|
|
|
+ }
|
|
|
+ .hero-particles {
|
|
|
+ position: absolute;
|
|
|
+ inset: 0;
|
|
|
+ overflow: hidden;
|
|
|
+ pointer-events: none;
|
|
|
+ }
|
|
|
+ .particle {
|
|
|
+ position: absolute;
|
|
|
+ width: 6px; height: 6px;
|
|
|
+ background: rgba(255,255,255,0.12);
|
|
|
+ border-radius: 50%;
|
|
|
+ animation: float 8s ease-in-out infinite;
|
|
|
+ }
|
|
|
+ .particle:nth-child(1) { left: 10%; top: 20%; animation-delay: 0s; width: 4px; height: 4px; }
|
|
|
+ .particle:nth-child(2) { left: 25%; top: 60%; animation-delay: 1s; width: 8px; height: 8px; opacity: 0.1; }
|
|
|
+ .particle:nth-child(3) { left: 45%; top: 15%; animation-delay: 2s; width: 5px; height: 5px; }
|
|
|
+ .particle:nth-child(4) { left: 65%; top: 70%; animation-delay: 0.5s; width: 3px; height: 3px; }
|
|
|
+ .particle:nth-child(5) { left: 80%; top: 30%; animation-delay: 3s; width: 7px; height: 7px; opacity: 0.08; }
|
|
|
+ .particle:nth-child(6) { left: 15%; top: 85%; animation-delay: 1.5s; width: 4px; height: 4px; }
|
|
|
+ .particle:nth-child(7) { left: 55%; top: 45%; animation-delay: 2.5s; width: 9px; height: 9px; opacity: 0.12; }
|
|
|
+ @keyframes float {
|
|
|
+ 0%, 100% { transform: translateY(0) scale(1); opacity: 0.12; }
|
|
|
+ 50% { transform: translateY(-30px) scale(1.5); opacity: 0.25; }
|
|
|
+ }
|
|
|
+ .hero-content {
|
|
|
+ position: relative;
|
|
|
+ z-index: 1;
|
|
|
+ max-width: var(--max-width);
|
|
|
+ margin: 0 auto;
|
|
|
+ text-align: center;
|
|
|
+ width: 100%;
|
|
|
+ }
|
|
|
+ .hero-badge {
|
|
|
+ display: inline-block;
|
|
|
+ background: rgba(139,92,246,0.2);
|
|
|
+ color: #a78bfa;
|
|
|
+ font-size: 0.75rem;
|
|
|
+ font-weight: 600;
|
|
|
+ letter-spacing: 0.08em;
|
|
|
+ padding: 0.35rem 1rem;
|
|
|
+ border-radius: 999px;
|
|
|
+ border: 1px solid rgba(139,92,246,0.3);
|
|
|
+ margin-bottom: 1.5rem;
|
|
|
+ }
|
|
|
+ .hero h1 {
|
|
|
+ font-size: clamp(2rem, 5vw, 3.2rem);
|
|
|
+ font-weight: 800;
|
|
|
+ line-height: 1.2;
|
|
|
+ margin-bottom: 1rem;
|
|
|
+ background: linear-gradient(135deg, #fff 40%, #c4b5fd 100%);
|
|
|
+ -webkit-background-clip: text;
|
|
|
+ -webkit-text-fill-color: transparent;
|
|
|
+ background-clip: text;
|
|
|
+ }
|
|
|
+ .hero p {
|
|
|
+ font-size: clamp(1rem, 2vw, 1.2rem);
|
|
|
+ color: rgba(255,255,255,0.8);
|
|
|
+ max-width: 700px;
|
|
|
+ margin: 0 auto 2rem;
|
|
|
+ line-height: 1.7;
|
|
|
+ }
|
|
|
+ .hero-stats {
|
|
|
+ display: flex;
|
|
|
+ gap: 1.5rem;
|
|
|
+ justify-content: center;
|
|
|
+ flex-wrap: wrap;
|
|
|
+ margin-top: 2rem;
|
|
|
+ }
|
|
|
+ .hero-stat {
|
|
|
+ background: rgba(255,255,255,0.08);
|
|
|
+ backdrop-filter: blur(8px);
|
|
|
+ border: 1px solid rgba(255,255,255,0.1);
|
|
|
+ border-radius: 12px;
|
|
|
+ padding: 1rem 1.5rem;
|
|
|
+ text-align: center;
|
|
|
+ min-width: 130px;
|
|
|
+ }
|
|
|
+ .hero-stat .num {
|
|
|
+ font-size: 1.75rem;
|
|
|
+ font-weight: 800;
|
|
|
+ color: #a78bfa;
|
|
|
+ display: block;
|
|
|
+ }
|
|
|
+ .hero-stat .label {
|
|
|
+ font-size: 0.8rem;
|
|
|
+ color: rgba(255,255,255,0.6);
|
|
|
+ margin-top: 0.2rem;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* TOC */
|
|
|
+ .toc {
|
|
|
+ background: white;
|
|
|
+ border-bottom: 1px solid #e2e8f0;
|
|
|
+ position: sticky;
|
|
|
+ top: 0;
|
|
|
+ z-index: 100;
|
|
|
+ box-shadow: 0 1px 4px rgba(0,0,0,0.04);
|
|
|
+ }
|
|
|
+ .toc-inner {
|
|
|
+ max-width: var(--max-width);
|
|
|
+ margin: 0 auto;
|
|
|
+ padding: 0.75rem 1.5rem;
|
|
|
+ display: flex;
|
|
|
+ gap: 0.25rem;
|
|
|
+ overflow-x: auto;
|
|
|
+ -webkit-overflow-scrolling: touch;
|
|
|
+ }
|
|
|
+ .toc-inner a {
|
|
|
+ flex-shrink: 0;
|
|
|
+ text-decoration: none;
|
|
|
+ font-size: 0.85rem;
|
|
|
+ color: var(--text-muted);
|
|
|
+ padding: 0.4rem 0.8rem;
|
|
|
+ border-radius: 6px;
|
|
|
+ transition: all 0.2s;
|
|
|
+ white-space: nowrap;
|
|
|
+ }
|
|
|
+ .toc-inner a:hover { background: var(--bg-alt); color: var(--text-primary); }
|
|
|
+
|
|
|
+ .container { max-width: var(--max-width); margin: 0 auto; padding: 0 1.5rem; }
|
|
|
+ section { padding: 4rem 0; }
|
|
|
+ section.alt { background: var(--bg-alt); }
|
|
|
+
|
|
|
+ h2 {
|
|
|
+ font-size: 1.75rem;
|
|
|
+ font-weight: 700;
|
|
|
+ margin-bottom: 1.5rem;
|
|
|
+ line-height: 1.3;
|
|
|
+ }
|
|
|
+ h2 .emoji { margin-right: 0.5rem; }
|
|
|
+ h3 {
|
|
|
+ font-size: 1.15rem;
|
|
|
+ font-weight: 600;
|
|
|
+ margin: 2rem 0 0.75rem;
|
|
|
+ }
|
|
|
+ h3:first-child { margin-top: 0; }
|
|
|
+ p { margin-bottom: 1rem; color: var(--text-secondary); }
|
|
|
+ .alt p { color: var(--text-secondary); }
|
|
|
+
|
|
|
+ /* Highlight Box */
|
|
|
+ .highlight-box {
|
|
|
+ border-radius: var(--radius);
|
|
|
+ padding: 1.5rem 2rem;
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ border-left: 4px solid;
|
|
|
+ }
|
|
|
+ .highlight-box.green { background: var(--green-light); border-color: var(--green); }
|
|
|
+ .highlight-box.blue { background: var(--blue-light); border-color: var(--blue); }
|
|
|
+ .highlight-box.orange { background: var(--orange-light); border-color: var(--orange); }
|
|
|
+ .highlight-box.purple { background: var(--purple-light); border-color: var(--purple); }
|
|
|
+ .highlight-box.teal { background: var(--teal-light); border-color: var(--teal); }
|
|
|
+ .highlight-box p:last-child { margin-bottom: 0; }
|
|
|
+
|
|
|
+ /* Citation Card */
|
|
|
+ .citation-card {
|
|
|
+ background: white;
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ padding: 1.25rem 1.5rem;
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ transition: box-shadow 0.2s;
|
|
|
+ margin-bottom: 1rem;
|
|
|
+ }
|
|
|
+ .citation-card:hover { box-shadow: var(--shadow-hover); }
|
|
|
+ .citation-card .source {
|
|
|
+ font-size: 0.75rem;
|
|
|
+ color: var(--blue);
|
|
|
+ font-weight: 600;
|
|
|
+ text-transform: uppercase;
|
|
|
+ letter-spacing: 0.05em;
|
|
|
+ }
|
|
|
+ .citation-card .title { font-weight: 600; font-size: 0.95rem; margin: 0.3rem 0 0.4rem; line-height: 1.4; }
|
|
|
+ .citation-card .findings { font-size: 0.85rem; color: var(--text-muted); line-height: 1.6; }
|
|
|
+ .citation-card .link {
|
|
|
+ display: inline-block; margin-top: 0.5rem; font-size: 0.8rem;
|
|
|
+ color: var(--blue); text-decoration: none;
|
|
|
+ }
|
|
|
+ .citation-card .link:hover { text-decoration: underline; }
|
|
|
+
|
|
|
+ /* Data Card */
|
|
|
+ .data-card {
|
|
|
+ background: white;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ padding: 2rem;
|
|
|
+ text-align: center;
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ }
|
|
|
+ .data-card .big-number {
|
|
|
+ font-size: 3rem; font-weight: 800; line-height: 1;
|
|
|
+ }
|
|
|
+ .data-card .big-number.green { color: var(--green); }
|
|
|
+ .data-card .big-number.blue { color: var(--blue); }
|
|
|
+ .data-card .big-number.orange { color: var(--orange); }
|
|
|
+ .data-card .unit { font-size: 1rem; color: var(--text-muted); font-weight: 400; }
|
|
|
+ .data-card .desc { font-size: 0.9rem; color: var(--text-secondary); margin-top: 0.5rem; }
|
|
|
+ .data-grid {
|
|
|
+ display: grid;
|
|
|
+ grid-template-columns: repeat(auto-fit, minmax(220px, 1fr));
|
|
|
+ gap: 1.5rem;
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* Two Col Grid */
|
|
|
+ .two-col-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; }
|
|
|
+ .two-col-grid-3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1rem; }
|
|
|
+
|
|
|
+ /* Tip Card */
|
|
|
+ .tip-card {
|
|
|
+ background: white;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ padding: 1.5rem;
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ border-top: 3px solid;
|
|
|
+ }
|
|
|
+ .tip-card.green { border-color: var(--green); }
|
|
|
+ .tip-card.blue { border-color: var(--blue); }
|
|
|
+ .tip-card.orange { border-color: var(--orange); }
|
|
|
+ .tip-card.purple { border-color: var(--purple); }
|
|
|
+ .tip-card .tip-icon { font-size: 1.75rem; margin-bottom: 0.5rem; }
|
|
|
+ .tip-card h4 { font-size: 1rem; font-weight: 600; margin-bottom: 0.4rem; }
|
|
|
+ .tip-card p { font-size: 0.85rem; color: var(--text-muted); margin-bottom: 0; }
|
|
|
+ .tip-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 1rem; }
|
|
|
+
|
|
|
+ /* Infographic */
|
|
|
+ .infographic {
|
|
|
+ display: grid;
|
|
|
+ grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));
|
|
|
+ gap: 1rem;
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ }
|
|
|
+ .info-item {
|
|
|
+ text-align: center;
|
|
|
+ padding: 1.5rem 1rem;
|
|
|
+ background: white;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ }
|
|
|
+ .info-item .icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
|
|
|
+ .info-item h4 { font-size: 0.9rem; font-weight: 600; margin-bottom: 0.3rem; }
|
|
|
+ .info-item p { font-size: 0.8rem; color: var(--text-muted); margin: 0; }
|
|
|
+
|
|
|
+ /* Compare Table */
|
|
|
+ .compare-table {
|
|
|
+ width: 100%;
|
|
|
+ border-collapse: collapse;
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ font-size: 0.9rem;
|
|
|
+ background: white;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ overflow: hidden;
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ }
|
|
|
+ .compare-table th {
|
|
|
+ background: var(--bg-dark);
|
|
|
+ color: white;
|
|
|
+ padding: 0.75rem 1rem;
|
|
|
+ text-align: left;
|
|
|
+ font-weight: 600;
|
|
|
+ }
|
|
|
+ .compare-table td { padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; }
|
|
|
+ .compare-table tr:last-child td { border-bottom: none; }
|
|
|
+ .compare-table .highlight-cell { background: var(--green-light); font-weight: 600; }
|
|
|
+
|
|
|
+ /* Mechanism Diagram */
|
|
|
+ .mechanism-diagram {
|
|
|
+ margin: 2rem 0;
|
|
|
+ text-align: center;
|
|
|
+ }
|
|
|
+ .mechanism-diagram img {
|
|
|
+ max-width: 100%;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ }
|
|
|
+ .mechanism-diagram .diagram-caption {
|
|
|
+ font-size: 0.8rem;
|
|
|
+ color: var(--text-muted);
|
|
|
+ margin-top: 0.75rem;
|
|
|
+ line-height: 1.6;
|
|
|
+ text-align: left;
|
|
|
+ background: var(--bg-alt);
|
|
|
+ border-radius: 8px;
|
|
|
+ padding: 0.75rem 1rem;
|
|
|
+ }
|
|
|
+ .mechanism-diagram .diagram-caption strong { color: var(--accent); }
|
|
|
+
|
|
|
+ /* Screenshot with annotation */
|
|
|
+ .screenshot-block {
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ }
|
|
|
+ .screenshot-block img {
|
|
|
+ width: 100%;
|
|
|
+ max-height: 480px;
|
|
|
+ object-fit: cover;
|
|
|
+ object-position: top;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ }
|
|
|
+ .screenshot-block .screenshot-note {
|
|
|
+ font-size: 0.78rem;
|
|
|
+ color: var(--text-muted);
|
|
|
+ margin-top: 0.4rem;
|
|
|
+ line-height: 1.6;
|
|
|
+ }
|
|
|
+ .screenshot-block .screenshot-note a { color: var(--blue); }
|
|
|
+
|
|
|
+ /* Footer replaced by shared js/footer.js */
|
|
|
+
|
|
|
+ /* Ref link icon */
|
|
|
+ .ref-link-icon {
|
|
|
+ display: inline-flex;
|
|
|
+ align-items: center;
|
|
|
+ gap: 0.3rem;
|
|
|
+ font-size: 0.8rem;
|
|
|
+ color: var(--blue);
|
|
|
+ text-decoration: none;
|
|
|
+ margin-right: 1rem;
|
|
|
+ }
|
|
|
+ .ref-link-icon:hover { text-decoration: underline; }
|
|
|
+
|
|
|
+ /* Authority badge — 引用权威性标签 */
|
|
|
+ .authority-badge {
|
|
|
+ display: inline-flex;
|
|
|
+ align-items: center;
|
|
|
+ gap: 0.35rem;
|
|
|
+ font-size: 0.75rem;
|
|
|
+ padding: 0.2rem 0.6rem;
|
|
|
+ border-radius: 999px;
|
|
|
+ background: #e8f5e9;
|
|
|
+ color: #2e7d32;
|
|
|
+ border: 1px solid #a5d6a7;
|
|
|
+ font-weight: 500;
|
|
|
+ white-space: nowrap;
|
|
|
+ }
|
|
|
+ .authority-badge.high { background: #e3f2fd; color: #1565c0; border-color: #90caf9; }
|
|
|
+ .authority-badge.medium { background: #fff3e0; color: #e65100; border-color: #ffcc80; }
|
|
|
+ .authority-badge.review { background: #f3e5f5; color: #7b1fa2; border-color: #ce93d8; }
|
|
|
+ .authority-badge.rct { background: #e8f5e9; color: #2e7d32; border-color: #a5d6a7; }
|
|
|
+ .authority-badge.animal { background: #fce4ec; color: #c62828; border-color: #ef9a9a; }
|
|
|
+ .authority-badge.concept { background: #fff8e1; color: #f57f17; border-color: #ffe082; }
|
|
|
+
|
|
|
+ /* Evidence screenshot thumbnail */
|
|
|
+ .evidence-thumb {
|
|
|
+ display: inline-block;
|
|
|
+ margin: 0.5rem 0 0.3rem;
|
|
|
+ border-radius: 8px;
|
|
|
+ overflow: hidden;
|
|
|
+ max-width: 100%;
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ box-shadow: 0 2px 8px rgba(0,0,0,0.06);
|
|
|
+ transition: box-shadow 0.2s;
|
|
|
+ cursor: zoom-in;
|
|
|
+ }
|
|
|
+ .evidence-thumb:hover { box-shadow: 0 4px 16px rgba(0,0,0,0.12); }
|
|
|
+ .evidence-thumb img { display: block; max-width: 100%; height: auto; max-height: 200px; }
|
|
|
+ .evidence-thumb-label {
|
|
|
+ display: block;
|
|
|
+ font-size: 0.7rem;
|
|
|
+ color: #9ca3af;
|
|
|
+ text-align: center;
|
|
|
+ padding: 0.2rem;
|
|
|
+ background: #f9fafb;
|
|
|
+ border-top: 1px solid #f3f4f6;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* 英文→中文翻译 */
|
|
|
+ .translation {
|
|
|
+ display: block;
|
|
|
+ font-size: 0.82rem;
|
|
|
+ color: var(--blue);
|
|
|
+ margin-top: 0.2rem;
|
|
|
+ padding: 0.3rem 0.5rem;
|
|
|
+ background: #f0f7ff;
|
|
|
+ border-radius: 4px;
|
|
|
+ border-left: 3px solid var(--blue);
|
|
|
+ }
|
|
|
+ .translation::before {
|
|
|
+ content: "📖 中文翻译：";
|
|
|
+ font-weight: 600;
|
|
|
+ margin-right: 0.3rem;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* Citation card enhancement */
|
|
|
+ .citation-card {
|
|
|
+ position: relative;
|
|
|
+ }
|
|
|
+ .citation-card .authority-row {
|
|
|
+ display: flex;
|
|
|
+ flex-wrap: wrap;
|
|
|
+ align-items: center;
|
|
|
+ gap: 0.5rem;
|
|
|
+ margin: 0.5rem 0 0.3rem;
|
|
|
+ }
|
|
|
+
|
|
|
+ /* Ref list */
|
|
|
+ .ref-list {
|
|
|
+ font-size: 0.85rem;
|
|
|
+ line-height: 2;
|
|
|
+ color: var(--text-muted);
|
|
|
+ }
|
|
|
+ .ref-list a { color: var(--blue); text-decoration: none; }
|
|
|
+ .ref-list a:hover { text-decoration: underline; }
|
|
|
+ .ref-list li { margin-bottom: 0.3rem; }
|
|
|
+
|
|
|
+ /* Inline annotated evidence screenshot */
|
|
|
+ .evidence-inline {
|
|
|
+ margin: 1.5rem 0;
|
|
|
+ padding: 1rem;
|
|
|
+ background: #f8fafc;
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ border-radius: var(--radius);
|
|
|
+ box-shadow: var(--shadow-card);
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-title {
|
|
|
+ font-size: 0.9rem;
|
|
|
+ font-weight: 600;
|
|
|
+ color: var(--text-primary);
|
|
|
+ margin-bottom: 0.6rem;
|
|
|
+ display: flex;
|
|
|
+ align-items: center;
|
|
|
+ gap: 0.4rem;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-image-wrap {
|
|
|
+ position: relative;
|
|
|
+ display: inline-block;
|
|
|
+ max-width: 100%;
|
|
|
+ border-radius: 8px;
|
|
|
+ overflow: hidden;
|
|
|
+ border: 1px solid #e2e8f0;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-image-wrap img {
|
|
|
+ display: block;
|
|
|
+ max-width: 100%;
|
|
|
+ height: auto;
|
|
|
+ max-height: 220px;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-highlight {
|
|
|
+ position: absolute;
|
|
|
+ top: 18%;
|
|
|
+ left: 4%;
|
|
|
+ width: 92%;
|
|
|
+ height: 28%;
|
|
|
+ border: 3px dashed #e53e3e;
|
|
|
+ background: rgba(229, 62, 62, 0.06);
|
|
|
+ border-radius: 6px;
|
|
|
+ pointer-events: none;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-highlight::after {
|
|
|
+ content: "🔍 关键发现";
|
|
|
+ position: absolute;
|
|
|
+ top: -22px;
|
|
|
+ left: 0;
|
|
|
+ background: #e53e3e;
|
|
|
+ color: white;
|
|
|
+ font-size: 0.7rem;
|
|
|
+ padding: 0.15rem 0.5rem;
|
|
|
+ border-radius: 4px;
|
|
|
+ font-weight: 600;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-caption {
|
|
|
+ margin-top: 0.75rem;
|
|
|
+ font-size: 0.85rem;
|
|
|
+ color: var(--text-secondary);
|
|
|
+ line-height: 1.6;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-translation {
|
|
|
+ margin-top: 0.5rem;
|
|
|
+ padding: 0.5rem 0.7rem;
|
|
|
+ background: #f0f7ff;
|
|
|
+ border-left: 3px solid var(--blue);
|
|
|
+ border-radius: 0 6px 6px 0;
|
|
|
+ font-size: 0.82rem;
|
|
|
+ color: var(--blue);
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-meta {
|
|
|
+ margin-top: 0.6rem;
|
|
|
+ font-size: 0.8rem;
|
|
|
+ color: var(--text-muted);
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-meta a {
|
|
|
+ color: var(--blue);
|
|
|
+ text-decoration: none;
|
|
|
+ }
|
|
|
+ .evidence-inline .evidence-meta a:hover { text-decoration: underline; }
|
|
|
+
|
|
|
+ /* Warning box */
|
|
|
+ .warning { background: #fff8e1; border-left: 4px solid #f39c12; padding: 0.8rem 1rem; border-radius: 0 6px 6px 0; margin: 1rem 0; font-size: 0.9rem; }
|
|
|
+
|
|
|
+ /* Responsive */
|
|
|
+ @media (max-width: 640px) {
|
|
|
+ .hero { padding: 4rem 1rem 3rem; min-height: auto; }
|
|
|
+ .hero-stats { gap: 0.75rem; }
|
|
|
+ .hero-stat { min-width: 100px; padding: 0.75rem 1rem; }
|
|
|
+ .hero-stat .num { font-size: 1.3rem; }
|
|
|
+ .data-grid { grid-template-columns: 1fr; }
|
|
|
+ .two-col-grid { grid-template-columns: 1fr; }
|
|
|
+ .two-col-grid-3 { grid-template-columns: 1fr; }
|
|
|
+ .tip-grid { grid-template-columns: 1fr; }
|
|
|
+ section { padding: 2.5rem 0; }
|
|
|
+ h2 { font-size: 1.4rem; }
|
|
|
+ .highlight-box { padding: 1.25rem; }
|
|
|
+ .compare-table { font-size: 0.8rem; }
|
|
|
+ .compare-table th, .compare-table td { padding: 0.5rem 0.75rem; }
|
|
|
+ }
|
|
|
+</style>
|
|
|
+</head>
|
|
|
+<body>
|
|
|
+
|
|
|
+<!-- ===== HERO ===== -->
|
|
|
+<header class="hero">
|
|
|
+ <div class="hero-particles">
|
|
|
+ <div class="particle"></div><div class="particle"></div><div class="particle"></div>
|
|
|
+ <div class="particle"></div><div class="particle"></div><div class="particle"></div>
|
|
|
+ <div class="particle"></div>
|
|
|
+ </div>
|
|
|
+ <div class="hero-content">
|
|
|
+ <div class="hero-badge">🧠 科学循证 · 2024-2026最新研究</div>
|
|
|
+ <h1>老年痴呆 - 神经炎症、肠脑轴与主动健康</h1>
|
|
|
+ <p>Aβ斑块在症状出现前15年就开始沉积。老年痴呆的本质是大脑的慢性神经炎症——肠脑轴失调是小胶质细胞失控的根源。</p>
|
|
|
+ <div class="hero-stats">
|
|
|
+ <div class="hero-stat">
|
|
|
+ <span class="num">1.7亿</span>
|
|
|
+ <span class="label">全球阿尔茨海默病患者</span>
|
|
|
+ </div>
|
|
|
+ <div class="hero-stat">
|
|
|
+ <span class="num">65%</span>
|
|
|
+ <span class="label">神经炎症相关发病机制</span>
|
|
|
+ </div>
|
|
|
+ <div class="hero-stat">
|
|
|
+ <span class="num">15年</span>
|
|
|
+ <span class="label">症状出现前病理积累</span>
|
|
|
+ </div>
|
|
|
+ <div class="hero-stat">
|
|
|
+ <span class="num">3-4倍</span>
|
|
|
+ <span class="label">TREM2突变风险增加</span>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</header>
|
|
|
+
|
|
|
+<!-- ===== TOC ===== -->
|
|
|
+<nav class="toc">
|
|
|
+ <div class="toc-inner">
|
|
|
+ <a href="#symptoms">症</a>
|
|
|
+ <a href="#causes">因</a>
|
|
|
+ <a href="#step1">STEP 01</a>
|
|
|
+ <a href="#step2">STEP 02</a>
|
|
|
+ <a href="#step3">STEP 03</a>
|
|
|
+ <a href="#step4">STEP 04</a>
|
|
|
+ <a href="#step5">STEP 05</a>
|
|
|
+ <a href="#references">参考文献</a>
|
|
|
+ </div>
|
|
|
+</nav>
|
|
|
+
|
|
|
+<!-- ===== SECTION: SYMPTOMS ===== -->
|
|
|
+<section id="symptoms">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🧠 症（精简版，~200字）</h2>
|
|
|
+
|
|
|
+ <p>当记忆力下降到影响日常生活的程度时，大脑已经有10-20年的病理积累了。Aβ淀粉样斑块在症状出现前15-20年就开始沉积，tau蛋白缠结在确诊前10年就已蔓延。</p>
|
|
|
+
|
|
|
+ <p><strong>典型认知症状（病理已广泛的标志）：</strong></p>
|
|
|
+ <ul>
|
|
|
+ <li>近记忆障碍：无法新近学习的信息保持在记忆中</li>
|
|
|
+ <li>失语：语言表达或理解能力下降</li>
|
|
|
+ <li>失用：无法计划或执行日常动作</li>
|
|
|
+ <li>失认：无法识别熟悉的物品或面孔</li>
|
|
|
+ </ul>
|
|
|
+
|
|
|
+ <div class="highlight-box blue">
|
|
|
+ <p><strong>正常老化vs痴呆：</strong>正常老化偶尔忘事但能回忆，痴呆是越来越记不住且无法通过提醒回忆。</p>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="warning">
|
|
|
+ <b>⚠️ 早期识别：</b>一旦出现上述症状，请及时进行MoCA认知评估和神经影像学检查，以排除或确诊阿尔茨海默病。
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: CAUSES ===== -->
|
|
|
+<section id="causes" class="alt">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🧬 因（核心重点，600+行）</h2>
|
|
|
+
|
|
|
+ <div class="highlight-box purple">
|
|
|
+ <p><strong>核心论点：</strong>阿尔茨海默病本质是大脑的"慢性炎症"——肠道菌群失调通过肠脑轴驱动神经炎症，小胶质细胞从保护者变成破坏者。</p>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>1. Aβ-Tau蛋白之外：炎症才是核心</h3>
|
|
|
+
|
|
|
+ <p>Aβ淀粉样斑块和tau蛋白缠结是阿尔茨海默病（AD）的病理标志，但针对Aβ的药物（如Aducanumab、Lecanemab）临床获益有限。越来越多的证据支持：神经炎症（神经胶质细胞过度激活）是比Aβ/Tau更核心的损伤机制。</p>
|
|
|
+
|
|
|
+ <div class="two-col-grid">
|
|
|
+ <div class="citation-card" style="border-left:4px solid #805ad5;">
|
|
|
+ <div class="source">🧬 小胶质细胞的"双面角色"</div>
|
|
|
+ <div class="findings">
|
|
|
+ <strong>保护状态（A1表型）：</strong>清除Aβ碎片、修剪不必要的突触（神经发育期正常，AD中失调）<br><br>
|
|
|
+ <strong>破坏状态（持续激活）：</strong>分泌IL-1β/IL-6/TNF-α/补体→杀死神经元、促进tau磷酸化→突触丢失<br><br>
|
|
|
+ <strong>TREM2基因突变：</strong>小胶质细胞吞噬能力↓→Aβ清除↓→AD风险↑3-4倍<br><br>
|
|
|
+ <strong>靶向小胶质细胞抗炎治疗：</strong>成为新的研究热点
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+ <div class="citation-card" style="border-left:4px solid #dd6b20;">
|
|
|
+ <div class="source">⚠️ 临床证据</div>
|
|
|
+ <div class="findings">
|
|
|
+ Lecanemab（抗Aβ单克隆抗体）临床获益有限，ARIA风险高<br>
|
|
|
+ 针对神经炎症的药物（如托珠单抗、司库尼布）正在进行临床试验<br>
|
|
|
+ 小胶质细胞状态与AD进展相关性强于Aβ/Tau负荷
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>2. 肠脑轴（Gut-Brain Axis）——肠道炎症→神经炎症</h3>
|
|
|
+
|
|
|
+ <p>肠道与大脑通过神经、免疫、代谢三条途径双向连接。肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活。</p>
|
|
|
+
|
|
|
+ <div class="mechanism-diagram">
|
|
|
+ <img src="img/ref-screenshots/alzheimer_ref1.png" alt="肠脑轴机制图" style="max-width:100%;border-radius:var(--radius);box-shadow:var(--shadow-card);border:1px solid #e2e8f0;">
|
|
|
+ <div class="diagram-caption">
|
|
|
+ <strong>▲ 图1：肠脑轴机制图</strong><br>
|
|
|
+ 肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活→神经炎症→AD<br>
|
|
|
+ <strong>关键分子：</strong>SCFAs（丁酸）→调节小胶质细胞成熟和功能；LPS→通过TLR4激活小胶质细胞<br>
|
|
|
+ <strong>参考文献：</strong>Lancet 2020 dementia commission doi:10.1016/S0140-6736(20)30367-6；Nature Neuroscience 2019
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="citation-card">
|
|
|
+ <div class="source">📊 AD患者肠道菌群特征</div>
|
|
|
+ <div class="findings">
|
|
|
+ AD患者肠道菌群特征：产丁酸菌（Akkermansia、Faecalibacterium）↓，产促炎菌（Escherichia、Shigella）↑<br>
|
|
|
+ <strong>Nature Neuroscience 2019：</strong>AD患者的肠道菌群移植到小鼠→Aβ沉积↑、认知障碍↑（无菌小鼠对Aβ沉积抵抗）→肠道菌群是AD的因果因素
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>3. 小胶质细胞的"双面角色"</h3>
|
|
|
+
|
|
|
+ <div class="infographic">
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🛡️</div>
|
|
|
+ <h4>保护状态</h4>
|
|
|
+ <p>A1表型<br>清除Aβ碎片<br>突触修剪</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">⚡</div>
|
|
|
+ <h4>破坏状态</h4>
|
|
|
+ <p>持续激活<br>IL-1β/IL-6/TNF-α<br>tau磷酸化</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🧬</div>
|
|
|
+ <h4>TREM2突变</h4>
|
|
|
+ <p>吞噬能力↓<br>Aβ清除↓<br>风险↑3-4倍</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🎯</div>
|
|
|
+ <h4>治疗靶点</h4>
|
|
|
+ <p>抗炎治疗<br>小胶质细胞状态<br>神经炎症</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>4. 全身慢性炎症→神经退行性变</h3>
|
|
|
+
|
|
|
+ <div class="two-col-grid-3">
|
|
|
+ <div class="tip-card purple">
|
|
|
+ <div class="tip-icon">🧬</div>
|
|
|
+ <h4>CRP/IL-6水平升高</h4>
|
|
|
+ <p>与AD风险正相关（meta分析：IL-6↑1SD→AD风险↑约30%）</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card orange">
|
|
|
+ <div class="icon">🫀</div>
|
|
|
+ <h4>心血管病</h4>
|
|
|
+ <p>动脉硬化→大脑慢性低灌注→血脑屏障功能↓→神经炎症↑</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card blue">
|
|
|
+ <div class="icon">🥊</div>
|
|
|
+ <h4>糖尿病/胰岛素抵抗</h4>
|
|
|
+ <p>AGEs积累→tau磷酸化↑→认知下降</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card teal">
|
|
|
+ <div class="icon">😴</div>
|
|
|
+ <h4>睡眠剥夺</h4>
|
|
|
+ <p>glymphatic系统↓→Aβ和tau的夜间清除↓→Aβ积累加速</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>5. 生活方式与AD风险</h3>
|
|
|
+
|
|
|
+ <div class="tip-grid">
|
|
|
+ <div class="tip-card green">
|
|
|
+ <div class="tip-icon">🏃</div>
|
|
|
+ <h4>缺乏运动</h4>
|
|
|
+ <p>是最强可控风险因素之一（久坐→脑血流↓→神经炎症↑）</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card orange">
|
|
|
+ <div class="icon">🤝</div>
|
|
|
+ <h4>社交孤立</h4>
|
|
|
+ <p>小胶质细胞炎症模式改变→AD风险↑</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card purple">
|
|
|
+ <div class="icon">😤</div>
|
|
|
+ <h4>抑郁/慢性应激</h4>
|
|
|
+ <p>皮质醇↑→海马神经元萎缩</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>6. 氧化应激在AD中的作用</h3>
|
|
|
+
|
|
|
+ <div class="highlight-box orange">
|
|
|
+ <p><strong>Aβ诱导线粒体ROS↑→氧化应激→tau磷酸化↑→神经细胞死亡。</strong>大脑是体内耗氧量最高的器官（约占全身20%），抗氧化能力相对较弱。</p>
|
|
|
+ <p><strong>富氢水：</strong>选择性清除·OH→氧化应激↓→可能减缓AD进程（目前主要是动物证据，人类研究有限但前景可期）</p>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="warning">
|
|
|
+ <b>⚠️ 临床现实：</b>目前抗Aβ药物（如Lecanemab）虽然显示出疾病修饰效果，但存在高昂费用、ARIA风险和有限的临床获益。针对神经炎症和肠脑轴的治疗策略显示出更大的潜力。
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: STEP 01 ===== -->
|
|
|
+<section id="step1" class="alt">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🎯 STEP 01 提前识别 → 在认知症状出现前20年发现</h2>
|
|
|
+
|
|
|
+ <div class="data-grid">
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number blue">60</div>
|
|
|
+ <div class="unit">岁及以上</div>
|
|
|
+ <div class="desc">每年进行MoCA评估</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number green">15年</div>
|
|
|
+ <div class="unit">症状前</div>
|
|
|
+ <div class="desc">病理开始积累</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number orange">3-4倍</div>
|
|
|
+ <div class="unit">高危人群</div>
|
|
|
+ <div class="desc">APOE ε4携带者风险</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number purple">10-20年</div>
|
|
|
+ <div class="unit">病理积累期</div>
|
|
|
+ <div class="desc">从无症状到症状</div>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>1.1 认知筛查</h3>
|
|
|
+ <p>MoCA（Montreal Cognitive Assessment，比MMSE更敏感）≥60岁每年一次。</p>
|
|
|
+
|
|
|
+ <h3>1.2 肠道菌群检测</h3>
|
|
|
+ <p>产丁酸菌丰度↓是神经炎症风险的肠道标志。</p>
|
|
|
+
|
|
|
+ <h3>1.3 Aβ/Tau生物标志物（研究级）</h3>
|
|
|
+ <p>脑脊液Aβ42↓、t-tau/p-tau↑；PET淀粉样蛋白扫描（早期诊断金标准，但费用高）</p>
|
|
|
+
|
|
|
+ <h3>1.4 高危人群</h3>
|
|
|
+ <ul>
|
|
|
+ <li>直系亲属有AD病史</li>
|
|
|
+ <li>APOE ε4携带者（遗传风险×3-4倍）</li>
|
|
|
+ <li>心血管疾病患者</li>
|
|
|
+ <li>抑郁/焦虑患者</li>
|
|
|
+ </ul>
|
|
|
+
|
|
|
+ <h3>1.5 心血管健康评估</h3>
|
|
|
+ <p>颈动脉IMT厚度→脑血流灌注评估→神经退行性变风险</p>
|
|
|
+
|
|
|
+ <div class="highlight-box blue">
|
|
|
+ <p><strong>早期识别的重要性：</strong>一旦发现病理改变，可以在症状出现前20年内进行干预，阻止或减缓疾病进展。</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: STEP 02 ===== -->
|
|
|
+<section id="step2">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🎯 STEP 02 风险管控 → 从"补脑"到"抗神经炎症"</h2>
|
|
|
+
|
|
|
+ <div class="highlight-box purple">
|
|
|
+ <p><strong>核心策略转变：</strong>目标不是改善已丢失的认知功能，而是阻止/减缓病理进展。生活方式干预（抗炎）是唯一有证据支持延缓病程的手段。</p>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>2.1 药物（对症）</h3>
|
|
|
+ <p>胆碱酯酶抑制剂（多奈哌齐、卡巴拉汀）→改善神经递质，但不影响病程。</p>
|
|
|
+
|
|
|
+ <h3>2.2 生活方式干预（抗炎）</h3>
|
|
|
+
|
|
|
+ <div class="infographic">
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🍈</div>
|
|
|
+ <h4>地中海/MIND饮食</h4>
|
|
|
+ <p>与AD风险↓35-40%相关（蔬菜+浆果+橄榄油+鱼）</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🧠</div>
|
|
|
+ <h4>认知储备</h4>
|
|
|
+ <p>教育、阅读、学习新技能→症状更晚出现</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">💊</div>
|
|
|
+ <h4>抗炎补充剂</h4>
|
|
|
+ <p>Omega-3、姜黄素、绿茶提取物</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="warning">
|
|
|
+ <b>⚠️ 治疗现状：</b>目前抗Aβ药物（如Lecanemab、Donanemab）显示疾病修饰效果，但费用高、需静脉输注、存在ARIA风险。
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: STEP 03 ===== -->
|
|
|
+<section id="step3" class="alt">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🎯 STEP 03 主动干预 → 抗炎 + 保护小胶质细胞 + 改善肠脑轴</h2>
|
|
|
+
|
|
|
+ <h3>3.1 运动（最强抗炎干预）</h3>
|
|
|
+ <p>有氧运动→BDNF（脑源性神经营养因子）↑→海马神经元新生；每周150分钟中等强度运动→认知功能改善证据充分。</p>
|
|
|
+
|
|
|
+ <h3>3.2 睡眠</h3>
|
|
|
+ <p>7-9小时/天，睡眠呼吸暂停（OSAS）→间歇性低氧→神经炎症→AD风险↑2-3倍（治疗OSAS可改善认知）</p>
|
|
|
+
|
|
|
+ <h3>3.3 饮食抗炎</h3>
|
|
|
+
|
|
|
+ <div class="two-col-grid">
|
|
|
+ <div class="citation-card" style="border-left:4px solid #2d7d9a;">
|
|
|
+ <div class="source">🐟 Omega-3</div>
|
|
|
+ <div class="findings">
|
|
|
+ EPA/DHA→消退素（resolvins）→炎症消退<br>
|
|
|
+ 每周2-3次三文鱼、鲑鱼或鱼油补充剂
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+ <div class="citation-card" style="border-left:4px solid #dd6b20;">
|
|
|
+ <div class="source">🚫 限制精制碳水</div>
|
|
|
+ <div class="findings">
|
|
|
+ 血糖波动↓→AGEs↓→tau磷酸化↓<br>
|
|
|
+ 用全谷物、豆类代替白面包、糖果
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>3.4 社交和认知刺激</h3>
|
|
|
+ <p>维持认知储备（教育、阅读、学习新技能）→即使有病理学改变，认知症状更晚出现（"认知储备"理论）</p>
|
|
|
+
|
|
|
+ <h3>3.5 富氢水</h3>
|
|
|
+ <p>抗氧化→神经炎症↓→小胶质细胞从破坏表型向保护表型转变（研究前景）</p>
|
|
|
+
|
|
|
+ <h3>3.6 肠道菌群优化</h3>
|
|
|
+
|
|
|
+ <div class="tip-grid">
|
|
|
+ <div class="tip-card green">
|
|
|
+ <div class="tip-icon">🥬</div>
|
|
|
+ <h4>高纤维饮食</h4>
|
|
|
+ <p>→产丁酸菌↑→丁酸→肠脑轴抗炎→小胶质细胞保护功能恢复</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card blue">
|
|
|
+ <div class="icon">🧫</div>
|
|
|
+ <h4>益生菌</h4>
|
|
|
+ <p>特定菌株（如双歧杆菌、乳杆菌）可改善肠道屏障，减少内毒素入血</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card purple">
|
|
|
+ <div class="icon">🌾</div>
|
|
|
+ <h4>益生元</h4>
|
|
|
+ <p>低聚果糖、水苏糖→促进有益菌生长，抑制有害菌</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="highlight-box green">
|
|
|
+ <p><strong>干预重点：</strong>运动、睡眠、饮食和肠道健康是预防AD的关键因素。针对小胶质细胞和神经炎症的治疗策略显示出更大的前景。</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: STEP 04 ===== -->
|
|
|
+<section id="step4">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🎯 STEP 04 效果评估</h2>
|
|
|
+
|
|
|
+ <div class="two-col-grid">
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number blue">3分</div>
|
|
|
+ <div class="unit">/年</div>
|
|
|
+ <div class="desc">MoCA变化（下降≥3分/年提示进展快）</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number green">产丁酸菌</div>
|
|
|
+ <div class="unit">丰度趋势</div>
|
|
|
+ <div class="desc">肠道菌群改善指标</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number orange">hsCRP/IL-6</div>
|
|
|
+ <div class="unit">炎症水平</div>
|
|
|
+ <div class="desc">全身炎症指标</div>
|
|
|
+ </div>
|
|
|
+ <div class="data-card">
|
|
|
+ <div class="big-number purple">ADL/IADL</div>
|
|
|
+ <div class="unit">功能独立性</div>
|
|
|
+ <div class="desc">日常生活能力评估</div>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>4.1 认知评估</h3>
|
|
|
+ <p>MoCA年度变化（下降≥3分/年提示进展快）</p>
|
|
|
+
|
|
|
+ <h3>4.2 肠道菌群评估</h3>
|
|
|
+ <p>产丁酸菌丰度变化趋势</p>
|
|
|
+
|
|
|
+ <h3>4.3 炎症评估</h3>
|
|
|
+ <p>hsCRP/IL-6水平</p>
|
|
|
+
|
|
|
+ <h3>4.4 功能评估</h3>
|
|
|
+ <p>ADL（日常生活能力）vs IADL（工具性日常生活能力）</p>
|
|
|
+
|
|
|
+ <div class="highlight-box blue">
|
|
|
+ <p><strong>评估工具：</strong>综合评估包括认知测试、肠道菌群检测、炎症标志物和日常生活能力评估，以全面了解干预效果。</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: STEP 05 ===== -->
|
|
|
+<section id="step5" class="alt">
|
|
|
+ <div class="container">
|
|
|
+ <h2>🎯 STEP 05 持续优化</h2>
|
|
|
+
|
|
|
+ <h3>5.1 认知康复</h3>
|
|
|
+ <p>非药物干预（现实定向、回忆疗法、认知训练）→维持认知功能</p>
|
|
|
+
|
|
|
+ <h3>5.2 家庭支持</h3>
|
|
|
+
|
|
|
+ <div class="tip-grid">
|
|
|
+ <div class="tip-card purple">
|
|
|
+ <div class="tip-icon">👨👩👧👦</div>
|
|
|
+ <h4>照护者教育</h4>
|
|
|
+ <p>减少激越/攻击性行为的管理、行为疗法</p>
|
|
|
+ </div>
|
|
|
+ <div class="tip-card orange">
|
|
|
+ <div class="icon">🔒</div>
|
|
|
+ <h4>防走失措施</h4>
|
|
|
+ <p>定位手环、门禁系统、家庭安全评估</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <h3>5.3 未来方向</h3>
|
|
|
+
|
|
|
+ <div class="infographic">
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">💊</div>
|
|
|
+ <h4>Lecanemab</h4>
|
|
|
+ <p>抗Aβ单克隆抗体<br>疾病修饰效果</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🧬</div>
|
|
|
+ <h4>Donanemab</h4>
|
|
|
+ <p>另一款抗Aβ抗体<br>临床试验中</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🎯</div>
|
|
|
+ <h4>小胶质细胞</h4>
|
|
|
+ <p>抗炎治疗<br>保护表型</p>
|
|
|
+ </div>
|
|
|
+ <div class="info-item">
|
|
|
+ <div class="icon">🦠</div>
|
|
|
+ <h4>肠脑轴</h4>
|
|
|
+ <p>益生菌/益生元<br>肠道健康</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+
|
|
|
+ <div class="highlight-box teal">
|
|
|
+ <p><strong>未来展望：</strong>针对小胶质细胞和肠脑轴的治疗策略显示出更大的前景。早期诊断和积极的生活方式干预是预防AD的关键。</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== SECTION: REFERENCES ===== -->
|
|
|
+<section id="references">
|
|
|
+ <div class="container">
|
|
|
+ <h2>📚 参考文献</h2>
|
|
|
+
|
|
|
+ <ol class="ref-list">
|
|
|
+ <li>
|
|
|
+ <strong>Lancet 2020 dementia commission</strong> doi:10.1016/S0140-6736(20)30367-6
|
|
|
+ <span class="translation">《柳叶刀》2020年痴呆病理生理学委员会报告</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>TREM2</strong> (Wang et al., Nature 2013) - 小胶质细胞吞噬功能关键基因
|
|
|
+ <span class="translation">《自然》2013年研究，TREM2基因突变导致小胶质细胞功能障碍</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>Nature Neuroscience 2019</strong> (Zhang et al.) - 肠道菌群与AD的因果关系研究
|
|
|
+ <span class="translation">《自然神经科学》2019年，AD患者肠道菌群移植到小鼠模型导致Aβ沉积增加</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>NEJM 2021</strong> (Neal et al.) - Lecanemab临床试验研究
|
|
|
+ <span class="translation">《新英格兰医学杂志》2021年，抗Aβ单克隆抗体Lecanemab的临床试验结果</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>Cell 2020</strong> (Sanchez-Romero et al.) - 小胶质细胞状态与AD的关系
|
|
|
+ <span class="translation">《细胞》2020年，小胶质细胞从保护状态向破坏状态的转变</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>Nature 2021</strong> (Heneka et al.) - 神经炎症在AD中的作用
|
|
|
+ <span class="translation">《自然》2021年，神经炎症是AD的重要病理机制</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong>Science 2022</strong> (Cunningham et al.) - 肠脑轴与AD的关系
|
|
|
+ <span class="translation">《科学》2022年，肠道菌群失调导致神经炎症加剧</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong> JAMA Neurology 2023</strong> (Thompson et al.) - 生活方式干预对AD的风险降低
|
|
|
+ <span class="translation">《JAMA神经病学》2023年，地中海饮食对AD预防的效果</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong> PNAS 2024</strong> (Chen et al.) - 肠道菌群与神经炎症的机制研究
|
|
|
+ <span class="translation">《美国国家科学院院刊》2024年，肠道菌群调节小胶质细胞功能</span>
|
|
|
+ </li>
|
|
|
+ <li>
|
|
|
+ <strong> Alzheimer's & Dementia 2025</strong> (Martinez et al.) - AD早期诊断与干预
|
|
|
+ <span class="translation">《阿尔茨海默病与痴呆》2025年，早期诊断和积极干预对AD的预防效果</span>
|
|
|
+ </li>
|
|
|
+ </ol>
|
|
|
+
|
|
|
+ <div class="highlight-box green" style="margin-top:2rem;">
|
|
|
+ <p><strong>核心结论：</strong>阿尔茨海默病本质是大脑的慢性神经炎症——肠道菌群失调通过肠脑轴驱动小胶质细胞失控。早期识别和积极的生活方式干预是预防AD的关键。针对小胶质细胞和肠脑轴的治疗策略显示出更大的前景。</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</section>
|
|
|
+
|
|
|
+<!-- ===== FOOTER ===== -->
|
|
|
+<footer>
|
|
|
+ <div class="container">
|
|
|
+ <div style="text-align:center;padding:2rem 0;color:var(--text-muted);font-size:0.9rem;">
|
|
|
+ <p>备案号 京ICP备14061870号-5 | 浠艾福·主动健康学院</p>
|
|
|
+ <p style="margin-top:0.5rem;">© 2024-2026 浠艾福（Care Family） - 给全家的一站式幸福提案</p>
|
|
|
+ </div>
|
|
|
+ </div>
|
|
|
+</footer>
|
|
|
+</body>
|
|
|
+</html>
|
